Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation

Journal of Gastroenterology

Volumn 47, Issue 7, 2012, Pages 795-804

  Schwenter, Frank ^a,b   Faughnan, Marie E ^c,d,e   Gradinger, Abigail B ^b   Berk, Terri ^b   Gryfe, Robert ^b   Pollett, Aaron ^b   Cohen, Zane ^b   Gallinger, Steven ^b   Durno, Carol ^b,f  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Arteriovenous malformation; Colorectal cancer screening; Colorectal polyps; Hereditary colorectal cancer

Indexed keywords

SMAD4 PROTEIN;

ADULT; ANEMIA; ARTICLE; CANCER PATIENT; CANCER RISK; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; DISEASE SURVEILLANCE; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HUMAN; JUVENILE POLYPOSIS; ONSET AGE; PATIENT IDENTIFICATION; PENETRANCE; PHENOTYPE; POLYPOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENDU OSLER WEBER DISEASE; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; GENETIC TESTING; HUMANS; INTESTINAL POLYPOSIS; MUTATION; NEOPLASTIC SYNDROMES, HEREDITARY; ONTARIO; PROSPECTIVE STUDIES; SMAD4 PROTEIN; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; YOUNG ADULT;

EID: 84864978712     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0545-8     Document Type: Article

References (45)

1. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet. 2004;363:852-9.
2. Westermann CJ, Rosina AF, De Vries V, de Coteau PA. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A. 2003;116A:324-8.
3. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32:291-7.
4. Bayrak-Toydemir P, Mao R, Lewin S, McDonald J. Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Genet Med. 2004;6:175-91.
5. Ference BA, Shannon TM, White RI Jr, Zawin M, Burdge CM. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest. 1994;106:1387-90.
6. Kjeldsen AD, Oxhoj H, Andersen PE, Green A, Vase P. Prevalence of pulmonary arteriovenous malformations (PAVMs) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia (HHT). J Intern Med. 2000;248:255-62.
7. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91:66-7.
8. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994;8:345-51.
9. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996;13:189-95.
10. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet. 2006;43:97-110.
11. Fernandez LA, Sanz-Rodriguez F, Blanco FJ, Bernabeu C, Botella LM. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res. 2006;4:66-78.
12. Wallace GM, Shovlin CL. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax. 2000;55:685-90.
13. Cole SG, Begbie ME, Wallace GM, Shovlin CL. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005;42:577-82.
14. Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A. 2006;140:2155-62.
15. Burt RW, Bishop DT, Lynch HT, Rozen P, Winawer SJ. Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990;68:655-65.
16. Jass JR, Williams CB, Bussey HJ, Morson BC. Juvenile polyposis-a precancerous condition. Histopathology. 1988;13:619-30.
17. Merg A, Howe JR. Genetic conditions associated with intestinal juvenile polyps. Am J Med Genet C Semin Med Genet. 2004;129C:44-55.
18. Rozen P, Samuel Z, Brazowski E, Jakubowicz M, Rattan J, Halpern Z. An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features. Fam Cancer. 2003;2:1-7.
19. Nugent KP, Talbot IC, Hodgson SV, Phillips RK. Solitary juvenile polyps: not a marker for subsequent malignancy. Gastroenterology. 1993;105:698-700.
20. Agnifili A, Verzaro R, Gola P, Marino M, Mancini E, Carducci G, et al. Juvenile polyposis: case report and assessment of the neoplastic risk in 271 patients reported in the literature. Dig Surg. 1999;16:161-6.
21. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol. 1998;5:751-6.
22. Brosens LA, van Hattem A, Hylind LM, Iacobuzio-Donahue C, Romans KE, Axilbund J, et al. Risk of colorectal cancer in juvenile polyposis. Gut. 2007;56:965-7.
23. Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet. 2001;28:184-7.
24. Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 1998;280:1086-8.
25. Howe JR, Sayed MG, Ahmed AF, Ringold J, Larsen-Haidle J, Merg A, et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet. 2004;41:484-91.
26. Baert AL, Casteels-Van Daele M, Broeckx J, Wijndaele L, Wilms G, Eggermont E. Generalized juvenile polyposis with pulmonary arteriovenous malformations and hypertrophic osteoarthropathy. AJR Am J Roentgenol. 1983;141:661-2.
27. Cox KL, Frates RC Jr, Wong A, Gandhi G. Hereditary generalized juvenile polyposis associated with pulmonary arteriovenous malformation. Gastroenterology. 1980;78:1566-70.
28. Inoue S, Matsumoto T, Iida M, Hoshika K, Shimizu M, Hisamoto N, et al. Juvenile polyposis occurring in hereditary hemorrhagic telangiectasia. Am J Med Sci. 1999;317:59-62.
29. Prieto G, Polanco I, Sarria J, Larrauri J, Lassaletta L. Association of juvenile and adenomatous polyposis with pulmonary arteriovenous malformation and hypertrophic osteoarthropathy. J Pediatr Gastroenterol Nutr. 1990;11:133-7.
30. Schumacher B, Frieling T, Borchard F, Hengels KJ. Hereditary hemorrhagic telangiectasia associated with multiple pulmonary arteriovenous malformations and juvenile polyposis. Z Gastroenterol. 1994;32:105-8.
31. Ballauff A, Koletzko S. Hereditary hemorrhagic telangiectasia with juvenile polyposis-coincidence or linked autosomal dominant inheritance? Z Gastroenterol. 1999;37:385-8.
32. Iyer NK, Burke CA, Leach BH, Parambil JG. SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia. Thorax. 2010;65:745-6.
33. Poletto ED, Trinh AM, Levin TL, Tsirilakis K, Loizides AM. Hereditary hemorrhagic telangiectasia and juvenile polyposis: an overlap of syndromes. Pediatr Radiol. 2010;40:1274-7.
34. Gallione CJ, Richards JA, Letteboer TG, Rushlow D, Prigoda NL, Leedom TP, et al. SMAD4 mutations found in unselected HHT patients. J Med Genet. 2006;43:793-7.
35. Faughnan ME, Granton JT, Young LH. The pulmonary vascular complications of hereditary haemorrhagic telangiectasia. Eur Respir J. 2009;33:1186-94.
36. Manfredi M. Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood. Gastroenterol Hepatol (NY). 2010;6:185-96.
37. Lesca G, Burnichon N, Raux G, Tosi M, Pinson S, Marion M-J, et al. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients. Hum Mutat. 2006;27:598.
38. Prigoda NL, Savas S, Abdalla SA, Piovesan B, Rushlow D, Vandezande K, et al. Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet. 2006;43:722-8.
39. Goldman K, De Pietro WP. A case of adenocarcinoma of the colon in a patient with hereditary hemorrhagic telangiectasis. Cutis. 1989;43:371-2.
40. Hisamura M, Akita K, Ide H. A case of Rendu-Osler-Weber disease associated with simultaneous, multiple advanced cancers in the colon. Hokkaido Igaku Zasshi. 1994;69:1468-75.
41. Lesca G, Olivieri C, Burnichon N, Pagella F, Carette M-F, Gilbert-Dussardier B, et al. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med. 2007;9:14-22.
42. Letteboer TGW, Mager JJ, Snijder RJ, Koeleman BPC, Lindhout D, Ploos van Amstel JK, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet. 2006;43:371-7.
43. Sabbà C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, et al. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost. 2007;5:1149-57.
44. Onaran L, Sahin B, Temucin G, Gököz A. Juvenile colonic polyposis associated with congenital heart disease. Dis Colon Rectum. 1978;21:501-5.
45. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48:73-87.